Counterpoint Mutual Funds’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$354K Sell
51,764
-478,102
-90% -$4.24M 0.03% 207
2026
Q2
$7.37M Buy
529,866
+497,145
+1,519% +$7.76M 0.73% 29
2026
Q1
$412K Buy
+32,721
New +$332K 0.06% 187
2025
Q4
– Sell
-39,556
Closed -$371K – 347
2025
Q3
$371K Buy
39,556
+722
+2% +$6.73K 0.03% 229
2025
Q2
$348K Sell
38,834
-192,850
-83% -$1.54M 0.03% 225
2025
Q1
$2.02M Buy
+231,684
New +$2.33M 0.29% 20
2024
Q1
– Sell
-18,801
Closed -$138K – 168
2023
Q4
$138K Buy
+18,801
New +$124K 0.05% 76

Other funds holding ADTN

Counterpoint Mutual Funds's ADTN Position: Q3 2026 in Review

Counterpoint Mutual Funds reduced its Adtran (ADTN) stake by 90% in Q3 2026, selling an estimated $4.24M and leaving 51,764 shares worth $354K. The position accounts for 0.03% of the portfolio, ranked #207.

Counterpoint Mutual Funds first reported a position in ADTN in Q4 2023 and has held it in 7 quarters since. The position peaked at $7.37M in Q2 2026. 42 funds tracked by Wall St. Rank hold ADTN as of Q3 2026.

  • Counterpoint Mutual Funds held 51,764 shares of Adtran worth $354K as of Q3 2026.
  • Counterpoint Mutual Funds sold 478,102 Adtran shares in Q3 2026, an estimated $4.24M.
  • Adtran made up 0.03% of Counterpoint Mutual Funds's portfolio in Q3 2026, its #207 holding.
  • Counterpoint Mutual Funds first reported a position in Adtran in Q4 2023 and has held it in 7 quarters since.
  • Counterpoint Mutual Funds's Adtran position peaked at $7.37M in Q2 2026.
  • 42 funds tracked by Wall St. Rank held Adtran as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.